Genosolutions Inc.

Sonogen was established to research, develop, and commercialize. Jason is a successful high tech entrepreneur with 20+ years technical project management and business leadership experience. Robert is a well-published and patent-holding biophysicist with twenty years of ultrasonics research and development experience. Alan is a world renowned scientist with decades of sonar experience and 11 patents in medical diagnostic and therapeutic ultrasound. Marc is a seasoned executive with over 25 years of development and commercialization experience in the medtech and biotech spaces, with multiple exits. Matt is a senior corporate and transactional attorney with over three decades’ experience representing a diverse range of closely held companies from startup to sale. Bill is the CEO of PrimePath Medtech, a boutique FDA regulatory consultancy that specializes in helping medical device startups bring their products to market. Nazarian is the President of the American Institute of Ultrasound in Medicine, Professor of Radiology at Hospital of the University of Pennsylvania, and Chief of Musculoskeletal Imaging at Penn Medicine.

The GeneOmics Solutions vision is early diagnosis and treatment in a personalized fashion using multi-omics data.​. Our mission is to support data-driven research for the discovery of novel biomarkers to develop innovative diagnostic and therapeutics for life-threatening diseases such as cancers, rare diseases, autoimmune and infectious diseases. To achieve our mission, we have gathered the best team with different backgrounds and expertise to build an Omics-MAP platform with end-to-end discovery pipelines and solutions to use multi-omics data for precision medicine. GeneOmics Solutions offering AI solutions for Better Diagnosis. Prathiba is a proficient and experienced scientist with expertise across bioinformatics and project management disciplines and accomplish various projects within biotech and academic settings. The integration of multi-omics data can provide a more comprehensive understanding of biological systems and can help to address complex biological problems such as disease diagnosis, drug development, and personalized medicine.​.

Our mission is to deliver a suite of unmatched molecular diagnostic to provide preventive, predictive, personalized services. Highly qualified experts are available to answer any queries and support medical professionals. Lab Genomics, LLC (LG) is focused on delivering individualized medical care through robust molecular and genetic diagnostics.

We are now excited to introduce the first ever fully customizable panels to make pet genetic testing even more affordable! GenSol was founded in 2008 to address the growing need for canine genetic screening and the everyday application of increasingly complex biological assays using state-of-the-art technology. GenSol Animal Diagnostics was founded in 2008 by Dr. Canine genetic testing provides veterinarians with an important tool for diagnosing genetic diseases. It provides the opportunity for tailored treatment approaches that help pet parents better understand their pet’s medical needs. Dog genetic testing is a great tool to understand your pet’s risk for known genetic conditions so you can make better healthcare and lifestyle decisions for your pet.

Ohad brings to GenXys a dynamic 20-year experience as an entrepreneur, public company executive and CEO in the digital health and medical device. Only the GenXys platform offers comprehensive decision support for both the pharmacists and physicians with workflow-specific tools to drive efficiency and outcomes at once. We are seeing more and more patients with PGx static reports. Partnering with GenXys positions us as the leader in personalized medicine and gives healthcare providers more confidence in the effectiveness of medical treatments, putting less strain on our health care system. Mark Gelfer has more than 20 years of experience with company creation as founder – CMO (VSM MedTech) and product development and commercialization (BpTRU). Professor Martin Dawes is a world expert in primary care who combines research and clinical practice with over 30 years of experience. Bernard Esquivel is a practicing physician-scientist, senior executive, and international leader with in-depth expertise developing new markets, devising compelling value propositions, go-to-market strategies, and launching programs to fulfill organizational goals and objectives in the healthcare space. Diana Dawes was one of the leading visionaries behind the establishment of GenXys.

Diagnomics envisions a future where cooperation between patients, physicians, and scientists enables a truly personalized medicine which recognizes patients as unique individuals and arms them with more accurate information about their genetic make-up. We are at the dawn of a new era in personalized medicine which allows us to use more effective therapies and treatments based on better insight into disease and personal health. Our vision is to develop complete solutions for personal genome profiling, sequencing and annotation, with the ultimate goal of integrating individual genomic sequencing into routine medical care. Diagnomics seeks to embrace the incredibly bright and hopeful future that personalized medicine provides, leading to improving individual well being. Diagnomics has a highly qualified team of scientists including early pioneers in sequencing the human genome. Additionally, Diagnomics has cutting edge genome presentation software as well as genome discovery expertise to guide the development of novel diagnostic tools and new therapeutic targets. Diagnomics opened its CLIA laboratory in 2016 and is accredited by the California Department of Public Health (CDPH). Established in 2011, Diagnomics is one of the first Next Generation Sequencing (NGS)-based genomics companies located in California.